Attached files

file filename
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR8.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR7.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR3.htm
10-Q - 10-Q - XENOPORT INCd700807d10q.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR20.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR27.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR10.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR5.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR26.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR21.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR16.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR14.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR13.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR15.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR19.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR23.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR11.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR12.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR18.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR1.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR17.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR24.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR22.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR6.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR2.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR32.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR31.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR30.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR28.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR29.htm
EXCEL - IDEA: XBRL DOCUMENT - XENOPORT INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR9.htm
XML - IDEA: XBRL DOCUMENT - XENOPORT INCR25.htm
EX-32.1 - EX-32.1 - XENOPORT INCd700807dex321.htm
EX-31.2 - EX-31.2 - XENOPORT INCd700807dex312.htm
EX-31.1 - EX-31.1 - XENOPORT INCd700807dex311.htm
EX-10.22 - EX-10.22 - XENOPORT INCd700807dex1022.htm
v2.4.0.8
STATEMENTS OF COMPREHENSIVE LOSS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
Product sales, net $ 2,957  
Collaboration revenue 283 379
Royalty revenue 135 80
Total revenues 3,375 459
Operating expenses:    
Cost of product sales 430  
Research and development 4,657 13,353
Selling, general and administrative 18,771 10,735
Total operating expenses 23,858 24,088
Loss from operations (20,483) (23,629)
Interest income 49 81
Interest expense (114)  
Net loss (20,548) (23,548)
Other comprehensive loss:    
Unrealized gains (losses) on available-for-sale securities (4) (19)
Comprehensive loss $ (20,552) $ (23,567)
Basic and diluted net loss per share $ (0.36) $ (0.50)
Shares used to compute basic and diluted net loss per share 56,887 47,249